GLP-1RAs Offer Better Renoprotection in Advanced Diabetic Kidney Disease
Previous GLP-1RA trials have mostly excluded patients with advanced diabetic kidney disease.
Previous GLP-1RA trials have mostly excluded patients with advanced diabetic kidney disease.
Results are from an indirect comparison of the FIDELITY and AMBER trials.
Investigators conducted a subgroup analysis of patients with eGFR values of 20 mL/min/1.73 m2 or less in the phase 3 ADVOCATE trial.
Combination talabostat and pembrolizumab has shown antitumor activity in patients who have metastatic castration-resistant prostate cancer with small-cell neuroendocrine carcinoma phenotype.
Sanofi is the third company to cut prices on its insulin products and cap out-of-pocket charges to $35 a month
Prophylaxis against Pneumocystis jirovecii pneumonia with trimethoprim-sulfamethoxazole reduced the risk for severe infections by nearly 77%, a study found.
Study findings suggest targeted inhibition of APOL1 function can reduce proteinuria.
Significant gains seen in 6-minute walk distance from baseline to week 24
News follows similar move made by Eli Lilly, which said earlier this month that it will cut insulin prices by 70%
Kidney transplant recipients are at high risk for hyperuricemia due to multiple contributing factors.